A Dominant Role for the Immunoproteasome in CD8+ T Cell Responses to Murine Cytomegalovirus

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Feb 10

PMID 21304910

Citations 54

Authors

Sarah Hutchinson

Stuart Sims

Geraldine OHara

Jon Silk

Uzi Gileadi

Vincenzo Cerundolo

Paul Klenerman

Affiliations

Soon will be listed here.

Abstract

Murine cytomegalovirus (MCMV) is an important animal model of human cytomegalovirus (HCMV), a β-Herpesvirus that infects the majority of the world's population and causes disease in neonates and immunocompromised adults. CD8(+) T cells are a major part of the immune response to MCMV and HCMV. Processing of peptides for presentation to CD8(+) T cells may be critically dependent on the immunoproteasome, expression of which is affected by MCMV. However, the overall importance of the immunoproteasome in the generation of immunodominant peptides from MCMV is not known. We therefore examined the role of the immunoproteasome in stimulation of CD8(+) T cell responses to MCMV - both conventional memory responses and those undergoing long-term expansion or "inflation". We infected LMP7(-/-) and C57BL/6 mice with MCMV or with newly-generated recombinant vaccinia viruses (rVVs) encoding the immunodominant MCMV protein M45 in either full-length or epitope-only minigene form. We analysed CD8(+) T cell responses using intracellular cytokine stain (ICS) and MHC Class I tetramer staining for a panel of MCMV-derived epitopes. We showed a critical role for immunoproteasome in MCMV affecting all epitopes studied. Interestingly we found that memory "inflating" epitopes demonstrate reduced immunoproteasome dependence compared to non-inflating epitopes. M45-specific responses induced by rVVs remain immunoproteasome-dependent. These results help to define a critical restriction point for CD8(+) T cell epitopes in natural cytomegalovirus (CMV) infection and potentially in vaccine strategies against this and other viruses.

Citing Articles

Effects of immunoproteasome inhibition on acute respiratory infection with murine hepatitis virus strain 1.

Steigmann J, Zhou X, Suttenberg L, Salman I, Rehmathullah Z, Weinberg J J Virol. 2024; 98(12):e0123824.

PMID: 39508578 PMC: 11650983. DOI: 10.1128/jvi.01238-24.

Memory inflation: Beyond the acute phase of viral infection.

Li Y, Xiao J, Li C, Yang M Cell Prolif. 2024; 57(12):e13705.

PMID: 38992867 PMC: 11628752. DOI: 10.1111/cpr.13705.

Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.

Holtappels R, Buttner J, Freitag K, Reddehase M, Lemmermann N Front Immunol. 2024; 15:1355153.

PMID: 38426094 PMC: 10902149. DOI: 10.3389/fimmu.2024.1355153.

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.

Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M Front Immunol. 2023; 14:1293090.

PMID: 38053994 PMC: 10694213. DOI: 10.3389/fimmu.2023.1293090.

'Stem-like' precursors are the fount to sustain persistent CD8 T cell responses.

Zehn D, Thimme R, Lugli E, de Almeida G, Oxenius A Nat Immunol. 2022; 23(6):836-847.

PMID: 35624209 DOI: 10.1038/s41590-022-01219-w.

References

Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski U . Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol. 2003; 170(4):2022-9. DOI: 10.4049/jimmunol.170.4.2022. View

Gold M, Munks M, Wagner M, Koszinowski U, Hill A, Fling S . The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J Immunol. 2002; 169(1):359-65. DOI: 10.4049/jimmunol.169.1.359. View

Chen W, Norbury C, Cho Y, Yewdell J, Bennink J . Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med. 2001; 193(11):1319-26. PMC: 2193381. DOI: 10.1084/jem.193.11.1319. View

Rock K, York I, Saric T, Goldberg A . Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol. 2002; 80:1-70. DOI: 10.1016/s0065-2776(02)80012-8. View

Palmowski M, Gileadi U, Salio M, Gallimore A, Millrain M, James E . Role of immunoproteasomes in cross-presentation. J Immunol. 2006; 177(2):983-90. DOI: 10.4049/jimmunol.177.2.983. View

Reddehase M . Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol. 2002; 2(11):831-44. DOI: 10.1038/nri932. View

Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S . A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med. 2005; 201(10):1543-53. PMC: 2212917. DOI: 10.1084/jem.20041401. View

Griffin T, Nandi D, Cruz M, Fehling H, Kaer L, Monaco J . Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med. 1998; 187(1):97-104. PMC: 2199179. DOI: 10.1084/jem.187.1.97. View

Muchamuel T, Basler M, Aujay M, Suzuki E, Kalim K, Lauer C . A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med. 2009; 15(7):781-7. DOI: 10.1038/nm.1978. View

10.

Peggs K, Verfuerth S, Pizzey A, Khan N, Guiver M, Moss P . Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet. 2003; 362(9393):1375-7. DOI: 10.1016/S0140-6736(03)14634-X. View

11.

Reddehase M, Keil G, Koszinowski U . The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors. Eur J Immunol. 1984; 14(1):56-61. DOI: 10.1002/eji.1830140111. View

12.

Klenerman P, Hill A . T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005; 6(9):873-9. DOI: 10.1038/ni1241. View

13.

Hengel H, Koszinowski U, Conzelmann K . Viruses know it all: new insights into IFN networks. Trends Immunol. 2005; 26(7):396-401. DOI: 10.1016/j.it.2005.05.004. View

14.

Reddehase M, Keil G, Koszinowski U . The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J Immunol. 1984; 132(1):482-9. View

15.

Munks M, Cho K, Pinto A, Sierro S, Klenerman P, Hill A . Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol. 2006; 177(1):450-8. DOI: 10.4049/jimmunol.177.1.450. View

16.

Hansen S, Vieville C, Whizin N, Coyne-Johnson L, Siess D, Drummond D . Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med. 2009; 15(3):293-9. PMC: 2720091. DOI: 10.1038/nm.1935. View

17.

Moss P, Khan N . CD8(+) T-cell immunity to cytomegalovirus. Hum Immunol. 2004; 65(5):456-64. DOI: 10.1016/j.humimm.2004.02.014. View

18.

Salem M, Hossain M . In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells. Int J Immunopharmacol. 2000; 22(9):707-18. DOI: 10.1016/s0192-0561(00)00033-3. View

19.

Karrer U, Wagner M, Sierro S, Oxenius A, Hengel H, Dumrese T . Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol. 2004; 78(5):2255-64. PMC: 369208. DOI: 10.1128/jvi.78.5.2255-2264.2004. View

20.

Fehling H, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U . MHC class I expression in mice lacking the proteasome subunit LMP-7. Science. 1994; 265(5176):1234-7. DOI: 10.1126/science.8066463. View